Mar 3, 2026 12:00PM

Feb 25, 2026 04:05PM

Feb 24, 2026 09:08AM

Feb 24, 2026 09:07AM

Jan 26, 2026 08:01AM

Jan 26, 2026 08:00AM

Jan 12, 2026 11:59AM Sarepta reports $1.86 billion in 2025 product revenue

Jan 12, 2026 11:58AM

Jan 12, 2026 09:30AM

Dec 9, 2025 06:50AM

Nov 25, 2025 08:58AM

Nov 25, 2025 08:57AM

Nov 24, 2025 07:31AM

Nov 24, 2025 07:30AM Sarepta Provides Progress Update for SRP-1003, its Investigational siRNA treatment for Myotonic Dystrophy Type 1

Nov 20, 2025 03:59AM

Nov 14, 2025 02:59PM

Nov 14, 2025 02:54PM

Nov 14, 2025 02:02PM

Nov 3, 2025 04:13PM

Nov 3, 2025 04:05PM

Oct 3, 2025 08:30AM Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2025 World Muscle Society Congress

Aug 13, 2025 04:13PM

Aug 13, 2025 04:12PM

Aug 12, 2025 01:25PM

Aug 11, 2025 01:59PM

Aug 6, 2025 04:05PM

Aug 5, 2025 06:28PM

Jul 30, 2025 08:07AM Sarepta Therapeutics (SRPT) PT Raised to $18 at Bernstein

Jul 30, 2025 06:40AM

Jul 29, 2025 10:27AM

Jul 29, 2025 10:05AM

Jul 29, 2025 09:37AM

Jul 29, 2025 08:41AM

Jul 29, 2025 07:22AM

Jul 29, 2025 07:20AM Sarepta Therapeutics (SRPT) PT Raised to $15 at Piper Sandler

Jul 29, 2025 06:55AM

Jul 29, 2025 05:42AM

Jul 29, 2025 04:05AM

Jul 29, 2025 03:19AM

Jul 28, 2025 05:23PM

Jul 28, 2025 05:10PM

Jul 28, 2025 05:09PM FDA Informs Sarepta That It Recommends That Sarepta Remove Its Pause and Resume Shipments of ELEVIDYS for Ambulatory Individuals With Duchenne Muscular Dystrophy

Jul 28, 2025 04:32PM

Jul 28, 2025 07:04AM

Jul 28, 2025 02:52AM

Jul 25, 2025 07:51PM

Jul 25, 2025 04:42PM

Jul 25, 2025 08:34AM

Jul 25, 2025 08:34AM Sarepta Therapeutics Acknowledges CHMP Negative Opinion for ELEVIDYS in the European Union

Jul 25, 2025 06:37AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All